
The Washington Post @washingtonpost
Officials said that work was already underway to transfer technology from Bavarian Nordic to Grand River Aseptic Manufacturing, and that manufacturing of the additional doses could begun later this year. https://t.co/lwzn17wmiu — PolitiTweet.org